Myall Katherine J, Martinovic Jennifer L, West Alex
Dept of Respiratory Medicine, Guys' and St Thomas' NHS Foundation Trust, London, UK.
Breathe (Sheff). 2022 Mar;18(1):210158. doi: 10.1183/20734735.0158-2021. Epub 2021 Mar 8.
The global pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has had far-reaching impacts on patients with interstitial lung disease (ILD), from diagnosis to management. In addition, after infection, persistent parenchymal change is associated with ongoing symptoms and functional impairment even in patients without pre-existing lung disease. The challenge of investigating and treating these patients has often fallen to ILD physicians. This review therefore seeks to explore the relationship between COVID-19 and the interstitium, as well as the model of care for patients with pre-existing ILD and those patients with persistent disease following recovery from their initial infection.
To understand the impact of the COVID-19 pandemic on patients with existing interstitial lung disease.To explore the development of interstitial lung disease after COVID-19 infection.
由严重急性呼吸综合征冠状病毒2（SARS-CoV-2）引起的全球大流行对间质性肺疾病（ILD）患者从诊断到管理都产生了深远影响。此外，感染后，即使在没有既往肺部疾病的患者中，持续性实质改变也与持续症状和功能损害相关。研究和治疗这些患者的挑战常常落在ILD医生身上。因此，本综述旨在探讨2019冠状病毒病（COVID-19）与间质之间的关系，以及对既往患有ILD的患者和初次感染康复后患有持续性疾病的患者的护理模式。
了解COVID-19大流行对现有间质性肺疾病患者的影响。探讨COVID-19感染后间质性肺疾病的发展。
